Scarica l'app Stockscreener
2.29
1.78%
0.04
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché INBS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.25
Aprire:
$2.25
Volume 24 ore:
64,197
Relative Volume:
0.55
Capitalizzazione di mercato:
$5.48M
Reddito:
$3.91M
Utile/perdita netta:
$-11.65M
Rapporto P/E:
-0.1859
EPS:
-12.3212
Flusso di cassa netto:
$-11.51M
1 W Prestazione:
-4.38%
1M Prestazione:
-37.26%
6M Prestazione:
-67.24%
1 anno Prestazione:
-87.62%
Intervallo 1D:
$2.25
$2.36
Intervallo di 1 settimana:
$2.25
$2.46
Portata 52W:
$2.24
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Nome
Intelligent Bio Solutions Inc
Settore
Industria
Telefono
646-790-5756
Indirizzo
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
2.29 | 5.48M | 3.91M | -11.65M | -11.51M | -12.32 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc Borsa (INBS) Ultime notizie
Intelligent Bio Solutions Inc (INBS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Intelligent Bio Solutions Inc (INBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Intelligent Bio Solutions Inc (INBS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions Inc (INBS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intelligent Bio Solutions Advances Codeine Drug Test Studies - TipRanks
Intelligent Bio Solutions launches interference study to support FDA 510(k) for codeine detection - TradingView
Interference study backs Intelligent Bio (NASDAQ: INBS) U.S. codeine test - Stock Titan
Intelligent Bio Solutions starts interference study for FDA submission By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions starts interference study for FDA submission - Investing.com
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry - TradingView
Intelligent Bio Solutions Initiates Interference Study to Support FDA 510(k) Submission for Drug Screening System - Quiver Quantitative
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Share Price, INBS Stock News, INBS Share Price & Updates - Kalkine
Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings - TradingView
INBS Q1 2025 Earnings: EPS Misses Estimates as Company Reports No RevenueProduct Revenue Analysis - newsline.com
INBS Q1 2025 Earnings: Earnings Miss Widens as Losses DeepenDividend Cut Risk - newsline.com
Intelligent Bio Solutions (INBS) Holds Near Support Amid Quiet Trading SessionMACD Signal Stocks - newsline.com
Intelligent Bio Solutions (INBS) Holds Steady Near Key Support After Modest PullbackGamma Exposure - newsline.com
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference Over June 16-18 - 富途牛牛
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 - marketscreener.com
Vegas microcap conference adds Intelligent Bio Solutions to lineup - Stock Titan
Intelligent Bio Solutions (INBS) Launches Study for Drug Screeni - GuruFocus
Intelligent Bio Solutions Launches Multi-Site Study for FDA 510(k) Clearance of Fingerprint Drug Screening System 1 - Minichart
Intelligent Bio Solutions Launches FDA Study for Codeine Test - TipRanks
Intelligent Bio Solutions starts FDA study for fingerprint drug test - Investing.com
Intelligent begins multi-site study to support FDA 510(k) for codeine screening - TradingView
Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study - Stock Titan
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission - The Manila Times
Fingerprint drug test put in workers' hands in new U.S. study - Stock Titan
Intelligent Bio Solutions (INBS) Edges Higher: Testing Key Resistance at $2.70Fundamental Weighted - newsline.com
INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Revenue Not Reported, Stock Rises 2.19%Earnings Weakness Phase - The Legal Advocate
Intelligent Bio Solutions (INBS) Climbs 4.4% as Shares Test Key Resistance Near $2.71Delta Hedging - newsline.com
INBS Q1 2025 Earnings: Wider-Than-Expected Loss as Revenue Remains AbsentShort-Term Outlook - newsline.com
Intelligent Bio Solutions (INBS) Surges 7% as Shares Rebound from Support LevelIntraday Trade Ideas - The Legal Advocate
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider Loss Than Expected Weighs on SharesInstitutional Grade Picks - Newser
Intelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider-Than-Expected Loss Amid Continued Pre-Revenue StageTrending Entry Points - Newser
INBS|Intelligent Bio Solutions Inc|Price:2.530|Chg%:-0.10 - TradingKey
Intelligent Bio Solutions Company Profile & Introduction - Moomoo
Intelligent Bio Solutions 3Q Loss $2.87M >INBS - Moomoo
INBS - Finviz
[SCHEDULE 13G] INTELLIGENT BIO SOLUTIONS INC. Passive Investment Disclosure (>5%) - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Intelligent Bio Solutions (INBS) Undervalued After Q3 FY2026 - GuruFocus
Intelligent Bio Solutions (NASDAQ: INBS) grows Q3 revenue 46% with margins above 50% - Stock Titan
Intelligent Bio Reports Q3 Revenue Up 46%, Gross Margin Over 50% as Cartridge Sales Surge - TradingView
Intelligent Bio Solutions Inc Azioni (INBS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):